CNTO 136

DRUG2 trials

Sponsors

Centocor, Inc., Janssen Research & Development, LLC

Conditions

HealthyLupus Nephritis

Phase 1

A Study of the Safety and How the Body Effects a Drug CNTO 136 in Healthy Male Japanese and Caucasian Volunteers

CompletedNCT00844909

Centocor, Inc.Healthy

Start: 2009-01-31End: 2009-08-31Updated: 2010-04-27

Phase 2

An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis

CompletedNCT01273389

Janssen Research & Development, LLCLupus Nephritis

Start: 2011-08-31End: 2013-09-30Updated: 2016-03-24